Monkey IFN-γ T cell ELISPOT antibody pair - 20-plate

SKU
CT605-20
Validated ELISPOT antibody pair; reagents available separately (1920 determinations).
Species reactivity: rhesus macaque, cynomolgus monkey, pig-tailed macaque, baboon and African green monkey.
Format
20-plate
Price
€ 1,160
Documentation
Data sheet
Manual
SDS
Reactivity
Monkey
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT antibody pairs are validated for high assay performance using the same reagents and materials included in U-CyTech ELISPOT kits. These antibody pairs are optimized for reliable and reproducible ELISPOT assays.
The antibody pairs are available in convenient 10-plate and 20-plate format, providing 960 or 1920 determinations, respectively.
Compatible reagents for ELISPOT assays can be purchased separately, allowing customization of your ELISPOT workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
574282

References

Authors, et al. Title Journal Year Volume Pages
Petra Mooij Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogens J Virol 2009 83 5881-9
Gul Ahmad Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model Vaccine 2009 27 2830-7
Bapi Pahar Control of viremia and maintenance of intestinal CD4(+) memory T cells in SHIV(162P3) infected macaques after pathogenic SIV(MAC251) challenge Virology 2009 387 273-84
Yichuan Wang Enhanced antibody responses elicited by a CpG adjuvant do not improve the protective effect of an aldrithiol-2-inactivated simian immunodeficiency virus therapeutic AIDS vaccine Clin Vaccine Immunol 2009 16 499-505
Robert Dubie Co-immunization with IL-15 enhances cellular immune responses induced by a vif-deleted simian immunodeficiency virus proviral DNA vaccine and confers partial protection against vaginal challenge with SIVmac251 Virology 2009 386 109-21
Kaushik Bharati Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta] Vaccine 2009 27 10-6
Babs Verstrepen Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates Vaccine 2008 26 3346-51
Ellen Sparger Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine Virology 2008 374 261-72
Petra Mooij Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates J Virol 2008 82 2975-88
Mariana Manrique DNA-MVA vaccine protection after X4 SHIV challenge in macaques correlates with day-of-challenge antiviral CD4+ cell-mediated immunity levels and postchallenge preservation of CD4+ T cell memory AIDS Res Hum Retroviruses 2008 24 505-19